Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +988.9% | +317.4% | 2 / 3 | +2485.0% | -26.51 pp | -0.01 pp | +0.5% | 0.00 | 91.55 | 561 | +2.485,0% | 4,3 | +2.435,8% | 91.55 | -35.95 | — |
| Pts | 12 | 12 | 8 | 12 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.500 (close price on 2026-10-19)EPS (TTM): 49,2
Financial charts
1.Revenue & growth
VND bn561Q2/26
1.Revenue & growth
VND bn561Q2/26
2.Profit & growth
VND bn2,68Q2/26
3.Profit mix (Penman)
VND bn3,34Q2/26
4.Margins & cost structure
%4.8%Q2/26
5.Returns & cash cycle
% · days-0.3%Q2/26
6.Earnings quality & cash
VND bn333Q2/26
7.Asset structure
VND bn282Q2/26
8.Funding & debt health
VND bn · times282Q2/26
9.Revenue backlog
VND bn4,62Q2/26
10.Valuation
times · %91,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %134Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-104%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26